| Justin Thomas White, MD | |
|
747 Broadway, Seattle, WA 98122-4307 | |
| (206) 386-6000 | |
| Not Available |
| Full Name | Justin Thomas White |
|---|---|
| Gender | Male |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 747 Broadway, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336699610 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Provider Name | University Of Louisville Physicians Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
Functional magnetic resonance imaging, or fMRI, has transformed our view of the brain, allowing researchers to pinpoint areas associated with everything from depression and dementia to playing chess and engaging in sex.
Not all biological weapons are created equal. They are separated into categories A through C, category A biological agents being the scariest: They are easy to spread, kill effectively and call for special actions by the pubic health system. One of these worrisome organisms is anthrax, which has already received its fair share of media attention. But work in Vince Fischetti's laboratory at Rockefeller University suggests that a newly discovered protein could be used to fight anthrax infections and even decontaminate areas in which anthrax spores have been released.
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the 725th event (patient death) has been reached in its pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy.
Those suffering from depressive symptoms have an increased risk for physical diseases, especially for arthrosis and arthritis. These findings were reported by researchers from the University of Basel and the Ruhr-University Bochum. Their results, based on data from 14,300 people living in Switzerland, have been published in the scientific journal "Frontiers in Public Health".
GOP presidential hopeful Mitt Romney has shifted to more moderate policy positions on a number of issues, including health care and abortion.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Justin Thomas White, MD 747 Broadway, Seattle, WA 98122-4379 Ph: (206) 386-6000 | Justin Thomas White, MD 747 Broadway, Seattle, WA 98122-4307 Ph: (206) 386-6000 |
News Archive
Functional magnetic resonance imaging, or fMRI, has transformed our view of the brain, allowing researchers to pinpoint areas associated with everything from depression and dementia to playing chess and engaging in sex.
Not all biological weapons are created equal. They are separated into categories A through C, category A biological agents being the scariest: They are easy to spread, kill effectively and call for special actions by the pubic health system. One of these worrisome organisms is anthrax, which has already received its fair share of media attention. But work in Vince Fischetti's laboratory at Rockefeller University suggests that a newly discovered protein could be used to fight anthrax infections and even decontaminate areas in which anthrax spores have been released.
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the 725th event (patient death) has been reached in its pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy.
Those suffering from depressive symptoms have an increased risk for physical diseases, especially for arthrosis and arthritis. These findings were reported by researchers from the University of Basel and the Ruhr-University Bochum. Their results, based on data from 14,300 people living in Switzerland, have been published in the scientific journal "Frontiers in Public Health".
GOP presidential hopeful Mitt Romney has shifted to more moderate policy positions on a number of issues, including health care and abortion.
› Verified 9 days ago